General Information of the Compound
| Compound ID |
CP0142770
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[4-(3-methylanilino)quinazolin-6-yl]prop-2-enamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
AWQLTDUXGVCRBV-UHFFFAOYSA-N
BDBM50077244
CHEMBL31815
N-(4-m-Tolylamino-quinazolin-6-yl)-acrylamide
N-[4-[(3-methyl-phenyl)amino]quinazolin-6-yl)acrylamide
N-[4-[(3-methyl-phenyl)amino]quinazolin-6-yl]acrylamide
SCHEMBL2991796
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C18H16N4O
|
||||||||||||||||||
| Molecular Weight |
304.353
|
||||||||||||||||||
| Canonical SMILES |
Cc1cccc(Nc2ncnc3ccc(NC(=O)C=C)cc23)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C18H16N4O/c1-3-17(23)21-14-7-8-16-15(10-14)18(20-11-19-16)22-13-6-4-5-12(2)9-13/h3-11H,1H2,2H3,(H,21,23)(H,19,20,22)
Show/Hide
|
||||||||||||||||||
| InChIKey |
AWQLTDUXGVCRBV-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound